vs
BELLRING BRANDS, INC.（BRBR）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是BELLRING BRANDS, INC.的1.2倍（$622.0M vs $537.3M），Royalty Pharma plc净利率更高（34.4% vs 8.1%，领先26.3%），Royalty Pharma plc同比增速更快（4.8% vs 0.8%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs 4.2%）
Bellring Brands是一家知名营养食品企业，研发、生产及销售蛋白饮料、蛋白棒、蛋白粉等功能性营养产品，旗下拥有Premier Protein、Dymatize等知名品牌，主要面向北美市场的健康及运动爱好者，通过零售、电商等多渠道发售。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
BRBR vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.2倍
$537.3M
营收增速更快
RPRX
高出3.9%
0.8%
净利率更高
RPRX
高出26.3%
8.1%
两年增速更快
RPRX
近两年复合增速
4.2%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $537.3M | $622.0M |
| 净利润 | $43.7M | $214.2M |
| 毛利率 | 29.9% | — |
| 营业利润率 | 14.6% | 62.4% |
| 净利率 | 8.1% | 34.4% |
| 营收同比 | 0.8% | 4.8% |
| 净利润同比 | -43.2% | 2.9% |
| 每股收益（稀释后） | $0.36 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BRBRRPRX
| Q4 25 | $537.3M | $622.0M | ||
| Q3 25 | $648.2M | $609.3M | ||
| Q2 25 | $547.5M | $578.7M | ||
| Q1 25 | $588.0M | $568.2M | ||
| Q4 24 | $532.9M | $593.6M | ||
| Q3 24 | $555.8M | $564.7M | ||
| Q2 24 | $515.4M | $537.3M | ||
| Q1 24 | $494.6M | $568.0M |
净利润BRBRRPRX
| Q4 25 | $43.7M | $214.2M | ||
| Q3 25 | $59.6M | $288.2M | ||
| Q2 25 | $21.0M | $30.2M | ||
| Q1 25 | $58.7M | $238.3M | ||
| Q4 24 | $76.9M | $208.2M | ||
| Q3 24 | $71.7M | $544.0M | ||
| Q2 24 | $73.7M | $102.0M | ||
| Q1 24 | $57.2M | $4.8M |
毛利率BRBRRPRX
| Q4 25 | 29.9% | — | ||
| Q3 25 | 28.9% | — | ||
| Q2 25 | 35.4% | — | ||
| Q1 25 | 32.3% | — | ||
| Q4 24 | 37.5% | — | ||
| Q3 24 | 36.9% | — | ||
| Q2 24 | 36.8% | — | ||
| Q1 24 | 33.2% | — |
营业利润率BRBRRPRX
| Q4 25 | 14.6% | 62.4% | ||
| Q3 25 | 15.8% | 70.1% | ||
| Q2 25 | 8.2% | 36.3% | ||
| Q1 25 | 16.2% | 94.0% | ||
| Q4 24 | 21.6% | 60.9% | ||
| Q3 24 | 20.2% | — | ||
| Q2 24 | 21.7% | 50.2% | ||
| Q1 24 | 18.4% | -13.0% |
净利率BRBRRPRX
| Q4 25 | 8.1% | 34.4% | ||
| Q3 25 | 9.2% | 47.3% | ||
| Q2 25 | 3.8% | 5.2% | ||
| Q1 25 | 10.0% | 41.9% | ||
| Q4 24 | 14.4% | 35.1% | ||
| Q3 24 | 12.9% | 96.3% | ||
| Q2 24 | 14.3% | 19.0% | ||
| Q1 24 | 11.6% | 0.8% |
每股收益（稀释后）BRBRRPRX
| Q4 25 | $0.36 | $0.49 | ||
| Q3 25 | $0.48 | $0.67 | ||
| Q2 25 | $0.16 | $0.07 | ||
| Q1 25 | $0.45 | $0.55 | ||
| Q4 24 | $0.59 | $0.46 | ||
| Q3 24 | $0.54 | $1.21 | ||
| Q2 24 | $0.56 | $0.23 | ||
| Q1 24 | $0.43 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $64.1M | $618.7M |
| 总债务越低越好 | $1.2B | $9.0B |
| 股东权益账面价值 | $-510.7M | $9.7B |
| 总资产 | $1.1B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资BRBRRPRX
| Q4 25 | $64.1M | $618.7M | ||
| Q3 25 | $71.8M | $938.9M | ||
| Q2 25 | $43.7M | $631.9M | ||
| Q1 25 | $28.1M | $1.1B | ||
| Q4 24 | $49.6M | $929.0M | ||
| Q3 24 | $70.8M | $950.1M | ||
| Q2 24 | $72.6M | $1.8B | ||
| Q1 24 | $79.3M | $843.0M |
总债务BRBRRPRX
| Q4 25 | $1.2B | $9.0B | ||
| Q3 25 | $1.1B | $8.9B | ||
| Q2 25 | $1.0B | $8.0B | ||
| Q1 25 | $953.7M | $7.6B | ||
| Q4 24 | $833.4M | $7.6B | ||
| Q3 24 | $833.1M | $7.6B | ||
| Q2 24 | $832.7M | $7.6B | ||
| Q1 24 | $832.4M | $6.1B |
股东权益BRBRRPRX
| Q4 25 | $-510.7M | $9.7B | ||
| Q3 25 | $-453.9M | $9.6B | ||
| Q2 25 | $-309.9M | $9.5B | ||
| Q1 25 | $-254.1M | $9.8B | ||
| Q4 24 | $-146.6M | $10.3B | ||
| Q3 24 | $-205.9M | $10.3B | ||
| Q2 24 | $-243.2M | $9.8B | ||
| Q1 24 | $-247.7M | $9.9B |
总资产BRBRRPRX
| Q4 25 | $1.1B | $19.6B | ||
| Q3 25 | $941.0M | $19.3B | ||
| Q2 25 | $993.7M | $18.3B | ||
| Q1 25 | $947.5M | $17.6B | ||
| Q4 24 | $885.2M | $18.2B | ||
| Q3 24 | $837.0M | $18.0B | ||
| Q2 24 | $804.1M | $17.7B | ||
| Q1 24 | $765.0M | $16.1B |
负债/权益比BRBRRPRX
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-3.1M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $-7.3M | — |
| 自由现金流率自由现金流/营收 | -1.4% | — |
| 资本支出强度资本支出/营收 | 0.8% | — |
| 现金转化率经营现金流/净利润 | -0.07× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $246.9M | — |
8季度趋势，按日历期对齐
经营现金流BRBRRPRX
| Q4 25 | $-3.1M | $827.1M | ||
| Q3 25 | $169.1M | $702.6M | ||
| Q2 25 | $40.3M | $364.0M | ||
| Q1 25 | $48.2M | $596.1M | ||
| Q4 24 | $3.0M | $742.5M | ||
| Q3 24 | $40.1M | $703.6M | ||
| Q2 24 | $69.0M | $658.2M | ||
| Q1 24 | $16.3M | $664.6M |
自由现金流BRBRRPRX
| Q4 25 | $-7.3M | — | ||
| Q3 25 | $168.1M | — | ||
| Q2 25 | $38.5M | — | ||
| Q1 25 | $47.6M | — | ||
| Q4 24 | $1.7M | — | ||
| Q3 24 | $38.9M | — | ||
| Q2 24 | $68.9M | — | ||
| Q1 24 | $16.0M | — |
自由现金流率BRBRRPRX
| Q4 25 | -1.4% | — | ||
| Q3 25 | 25.9% | — | ||
| Q2 25 | 7.0% | — | ||
| Q1 25 | 8.1% | — | ||
| Q4 24 | 0.3% | — | ||
| Q3 24 | 7.0% | — | ||
| Q2 24 | 13.4% | — | ||
| Q1 24 | 3.2% | — |
资本支出强度BRBRRPRX
| Q4 25 | 0.8% | — | ||
| Q3 25 | 0.2% | — | ||
| Q2 25 | 0.3% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 0.2% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.1% | — |
现金转化率BRBRRPRX
| Q4 25 | -0.07× | 3.86× | ||
| Q3 25 | 2.84× | 2.44× | ||
| Q2 25 | 1.92× | 12.06× | ||
| Q1 25 | 0.82× | 2.50× | ||
| Q4 24 | 0.04× | 3.57× | ||
| Q3 24 | 0.56× | 1.29× | ||
| Q2 24 | 0.94× | 6.45× | ||
| Q1 24 | 0.28× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BRBR
| Shakesandotherbeverages | $432.4M | 80% |
| Powders | $92.1M | 17% |
| Other Products | $12.8M | 2% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
